Showing results (2041-2050 of 3,033) with videos related to
Sort By:
Pageof 304
Scientific Reports|January 8, 2022
Predicting pathogenicity for novel hearing loss mutations based on genetic and protein structure approachesPaula I Buonfiglio, Carlos D Bruque, Vanesa Lotersztein, et al.Annals of Hematology|August 23, 2016
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocolMoshe Mittelman, Kalman Filanovsky, Yishai Ofran, et al.Leukemia & Lymphoma|November 6, 2019
The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparisonMaria-Victoria Mateos, Jesus San-Miguel, Hartmut Goldschmidt, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|March 21, 2007
Functional evidence of des-Arg10-kallidin enzymatic inactivating pathway in isolated human umbilical veinWanda Nowak, Ezequiel Dario Goldschmidt, Alejandra Georgina Falcioni, et al.Hepatology (Baltimore, Md.)|October 24, 2006
Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in miceSteve S Choi, Jason K Sicklick, Qi Ma, et al.Cancer Genetics and Cytogenetics|May 10, 2006
Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevanceI G H Schmidt-Wolf, A Glasmacher, C Hahn-Ast, et al.Water Environment Research : a Research Publication of the Water Environment Federation|September 4, 2022
Key enzymes involved in anammox-based processes for wastewater treatment: An applied overviewBruno Venturin, Heloisa Campeão Rodrigues, Gabriela Bonassa, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1998
Priming of platelet alphaIIbbeta3 by oxidants is associated with tyrosine phosphorylation of beta3K Irani, Y Pham, L D Coleman, et al.British Journal of Cancer|January 1, 1997
Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapyE Brain, C Garrino, J L Misset, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2015
Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimensTilmann Bochtler, Ute Hegenbart, Christina Kunz, et al.Pageof 304